scispace - formally typeset
K

Kenmin Wu

Researcher at Memorial Sloan Kettering Cancer Center

Publications -  6
Citations -  1706

Kenmin Wu is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Immune system & Cancer. The author has an hindex of 4, co-authored 5 publications receiving 1086 citations. Previous affiliations of Kenmin Wu include Howard Hughes Medical Institute.

Papers
More filters
Journal ArticleDOI

Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment.

TL;DR: A preprocessing pipeline, SEQC, and a Bayesian clustering and normalization method, Biscuit, are developed to address computational challenges inherent to single-cell data and support a model of continuous activation in T cells and do not comport with the macrophage polarization model in cancer.
Journal ArticleDOI

Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer.

TL;DR: These studies suggest that targeting CCR8 for the depletion of tumor-resident Treg cells might represent a promising immunotherapeutic approach for the treatment of breast cancer.
Posted ContentDOI

Single-Cell Immune Map of Breast Carcinoma Reveals Diverse Phenotypic States Driven by the Tumor Microenvironment

TL;DR: The results argue against discrete activation states in T cells and the polarization model of macrophage activation in cancer, with important implications for characterizing tumor-infiltrating immune cells.
Journal ArticleDOI

Phase I/II study of mogamulizumab, an anti-CCR4 antibody targeting regulatory T cells in advanced cancer patients.

TL;DR: This data indicates that Treg-positive B cell reprograming acts as a “spatially aggregating force” to reprogram CD4 T cells to regulate immune homeostasis in mice with EMT.